Oral drug blocks SARS-CoV-2 transmission, Georgia State biomedical sciences researchers find
ATLANTA--Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University…

You must be logged in to post a comment.